Valorisations sectorielles Larimar Therapeutics, Inc.
Actions
LRMR
US5171251003
Recherche biotechnologique et médicale
|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 3,820 USD | -0,13% |
|
-4,50% | +0,26% |
| 29/06 | Transcript : Larimar Therapeutics, Inc. - Special Call | |
| 29/06 | Larimar Therapeutics dépose le premier module de sa demande de licence biologique auprès de la FDA pour le nomlabofusp | MT |
Principaux concurrents
Ajouter à une liste 0 sélectionné | PER (Y) | Price to Book (Y) | PEG (Y) | VE / CA (Y) | VE / EBITDA (Y) | VE / EBIT (Y) | Rendement du dividende (Y) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
| -2.37x | 3.23x | 0.08x | - | -1.41x | -1.36x | -.--% | 399 M | ||
| 21.25x | 4.11x | -2.49x | 6.51x | 14.24x | 16.4x | 1,5% | 56,54 Md | ||
| 31.6x | 6x | 0.82x | 7.8x | 24.02x | 24.51x | 0,05% | 53,6 Md | ||
| -17.91x | 1.1x | 2.77x | 4.18x | -7.32x | -6.17x | -.--% | 22,91 Md | ||
| -38.06x | 49.84x | 0.64x | 12.21x | -36.05x | -39.58x | -.--% | 21,37 Md | ||
| 25.45x | 2.49x | 1.95x | 4.98x | 13.18x | 15.76x | -.--% | 20,27 Md | ||
| 24.28x | 2.75x | -1.15x | 4.73x | 15.36x | 17.32x | -.--% | 17,56 Md | ||
| -737.38x | 18.22x | 11.3x | 35.03x | -3943.97x | -495.61x | -.--% | 14,75 Md | ||
| 40.7x | 10.44x | 0.36x | 16.37x | 42.16x | 38.68x | 0,09% | 13,53 Md | ||
| 16.73x | 4.75x | 1.19x | 4.82x | 11.24x | 12.14x | -.--% | 13,33 Md | ||
| -26.07x | 28.14x | -0x | 24.96x | -31.27x | -24.97x | -.--% | 11,92 Md | ||
| -5064.4x | 7.82x | 51.31x | 13.72x | 91.49x | 407.38x | -.--% | 11,04 Md | ||
| -70.04x | 24.05x | 1.46x | 6.77x | -55.74x | -51.61x | -.--% | 10,8 Md | ||
| -12.07x | -83.8x | 5.34x | 87.58x | -13.65x | -13.27x | -.--% | 10,47 Md | ||
| -10.72x | 38.23x | 0.7x | 2390.94x | -12.67x | -11.01x | -.--% | 10,39 Md | ||
| -17.7x | 8.8x | 3.79x | 113.46x | -15.87x | -14.42x | - | 8,81 Md | ||
| -32x | 8.79x | -0.58x | - | -29.57x | -28.61x | -.--% | 8,65 Md | ||
| 11.62x | 5.71x | 0.03x | 7.27x | 11.67x | 10.81x | -.--% | 8,08 Md | ||
| Moyenne | -325,39x | 7,81x | 4,31x | 171,33x | -218,01x | -7,98x | 0,1% | 17,47 Md | |
| Moyenne pondérée par Capi. | -206,81x | 8,33x | 2,74x | 96,48x | -179,04x | -5,23x | 0,29% |
- Bourse
- Actions
- Action LRMR
- Secteur Larimar Therapeutics, Inc.
- Valorisations sectorielles
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
















